SYMETIS

Symetis a obtenu l’homologation de certification CE pour son système d’implantation de valve aortique transcathter ACURATE neo(TM) et lance son produit pour des premières implantations commerciales – BioMedReports...

SYMETIS

12th September 2014 – Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations...

SYMETIS

26th September 2013 – Symetis and Endoluminal Sciences enter into a license agreement to develop 3rd generation TAVI Pdf
6914c0f83c2405faf90b7845e3d48965uuuuuuuuuuuuuuuuuuuuuuuuu